Analyst Reiterates Overweight Rating on Nano-X Imaging Post NVIDIA Investment News
InvestingFeb 15 23:02
Cantor Fitzgerald Reiterates Overweight on Nano X Imaging, Maintains $18 Price Target
BenzingaFeb 15 22:24
Nano X Imaging Analyst Ratings
BenzingaFeb 15 22:21
Nano X Imaging Analyst Ratings
BenzingaJan 19 23:52
Nano X Imaging Analyst Ratings
BenzingaNov 29, 2023 22:34
Cantor Fitzgerald Reiterates Overweight on Nano X Imaging, Maintains $30 Price Target
BenzingaOct 3, 2023 21:36
Nano X Imaging Analyst Ratings
BenzingaOct 3, 2023 21:33
Cantor Fitzgerald Reiterates Overweight on Nano X Imaging, Maintains $30 Price Target
BenzingaSep 26, 2023 23:47
Nano X Imaging Analyst Ratings
BenzingaSep 26, 2023 23:47
Nano X Imaging Analyst Ratings
BenzingaSep 8, 2023 20:41
Nano X Imaging Analyst Ratings
BenzingaAug 22, 2023 23:38
Cantor Fitzgerald Reiterates Overweight on Nano X Imaging, Maintains $30 Price Target
BenzingaAug 18, 2023 22:48
Nano X Imaging Analyst Ratings
BenzingaAug 18, 2023 22:47
Cantor Fitzgerald Reiterates Overweight on Nano X Imaging, Maintains $30 Price Target
BenzingaJun 14, 2023 23:17
Watching Nano-X Imaging; Hearing Cantor Fitzgerald Says Co Won A Large Hospital Contract In Europe, Notably, ARC System At CHU University Hospital In Marrakech, Reiterating Its Overweight Rating And $30 Price Target
BenzingaJun 14, 2023 22:44
Cantor Fitzgerald Maintains Overweight on Nano X Imaging, Raises Price Target to $30
BenzingaMay 24, 2023 19:28
Cantor Fitzgerald Adjusts Nano-X Imaging Price Target to $30 From $21, Maintains Overweight Rating
MT NewswiresMay 23, 2023 23:35
No Data
No Data